R. Tohn

Structure‐guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non‐obese diabetic mice

S. Haeryfar, P. Savage, T. Delovitch, 2011, Clinical and experimental immunology.

NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice

D. Ly, I. Maričić, J. Månsson, 2012, PloS one.

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes

S. Haeryfar, S. Porcelli, N. Veerapen, 2011, Clinical and experimental immunology.

An α‐galactosylceramide C20:2 N‐acyl variant enhances anti‐inflammatory and regulatory T cell‐independent responses that prevent type 1 diabetes

S. Porcelli, N. Veerapen, B. Rubin, 2009, Clinical and experimental immunology.

Characterization of Cross-Reactive CD8+ T-Cell Recognition of HLA-A2-Restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) Epitopes in Individuals Infected with Human Immunodeficiency and Hepatitis C Viruses

R. Kaul, M. Ostrowski, C. Kovacs, 2010, Journal of Virology.

Correction: NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice

D. Ly, I. Maričić, J. Månsson, 2012, PLoS ONE.